{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:15:08Z","timestamp":1784081708669,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JSGG20200225151410198"],"award-info":[{"award-number":["JSGG20200225151410198"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["COVID190123"],"award-info":[{"award-number":["COVID190123"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012479","name":"General Research Fund of Shanghai Normal University","doi-asserted-by":"publisher","award":["T11-709\/21-N"],"award-info":[{"award-number":["T11-709\/21-N"]}],"id":[{"id":"10.13039\/501100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012479","name":"General Research Fund of Shanghai Normal University","doi-asserted-by":"publisher","award":["17117422"],"award-info":[{"award-number":["17117422"]}],"id":[{"id":"10.13039\/501100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012479","name":"General Research Fund of Shanghai Normal University","doi-asserted-by":"publisher","award":["17123422"],"award-info":[{"award-number":["17123422"]}],"id":[{"id":"10.13039\/501100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012479","name":"General Research Fund of Shanghai Normal University","doi-asserted-by":"publisher","award":["17119723"],"award-info":[{"award-number":["17119723"]}],"id":[{"id":"10.13039\/501100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012479","name":"General Research Fund of Shanghai Normal University","doi-asserted-by":"publisher","award":["17121420"],"award-info":[{"award-number":["17121420"]}],"id":[{"id":"10.13039\/501100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012479","name":"General Research Fund of Shanghai Normal University","doi-asserted-by":"publisher","award":["17119820"],"award-info":[{"award-number":["17119820"]}],"id":[{"id":"10.13039\/501100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012479","name":"General Research Fund of Shanghai Normal University","doi-asserted-by":"publisher","award":["T11-706\/18-N"],"award-info":[{"award-number":["T11-706\/18-N"]}],"id":[{"id":"10.13039\/501100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007156","name":"Innovation and Technology Commission - Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"University Grants Committee Research Grants Council","doi-asserted-by":"publisher","award":["C7156-20GF"],"award-info":[{"award-number":["C7156-20GF"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ebiom.2025.105699","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T15:08:37Z","timestamp":1744816117000},"page":"105699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["An open-label study on the safety and immunogenicity of a PD-1-enhanced DNA vaccine used as a T cell booster for COVID-19"],"prefix":"10.1016","volume":"115","author":[{"given":"Yik Chun","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek Hoi","family":"Hang Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin Fai","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Yin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Po","family":"Polly Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Ki","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4511-2888","authenticated-orcid":false,"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1556-2538","authenticated-orcid":false,"given":"Ivan F.N.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.105699_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41586-020-2918-0","article-title":"Age-specific mortality and immunity patterns of SARS-CoV-2","volume":"590","author":"O'Driscoll","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105699_bib2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/science.abm0620","article-title":"SARS-CoV-2 vaccine protection and deaths among US veterans during 2021","volume":"375","author":"Cohn","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2025.105699_bib3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2025.105699_bib4","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.immuni.2020.07.026","article-title":"Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses","volume":"53","author":"Zhou","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2025.105699_bib5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105699_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103762","article-title":"Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models","volume":"75","author":"Zhou","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2025.105699_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2025.105699_bib8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.immuni.2023.02.017","article-title":"SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses","volume":"56","author":"Koutsakos","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2025.105699_bib9","article-title":"Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals","volume":"2","author":"Tarke","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ebiom.2025.105699_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","article-title":"Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2","volume":"596","author":"Collier","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105699_bib11","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2025.105699_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s43587-023-00379-0","article-title":"Insufficient epitope-specific T cell clones are responsible for impaired cellular immunity to inactivated SARS-CoV-2 vaccine in older adults","volume":"3","author":"Xiao","year":"2023","journal-title":"Nat Aging"},{"key":"10.1016\/j.ebiom.2025.105699_bib13","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1172\/JCI64704","article-title":"PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice","volume":"123","author":"Zhou","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2025.105699_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042403","article-title":"Evaluating cellular polyfunctionality with a novel polyfunctionality index","volume":"7","author":"Larsen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2025.105699_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/325720","article-title":"High throughput T epitope mapping and vaccine development","volume":"2010","author":"Li Pira","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.ebiom.2025.105699_bib16","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2025.105699_bib17","series-title":"COVID-19 vaccines: safety surveillance manual","year":"2020"},{"key":"10.1016\/j.ebiom.2025.105699_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41541-021-00331-6","article-title":"Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation","volume":"6","author":"Meyers","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ebiom.2025.105699_bib19","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jaci.2020.03.017","article-title":"Influence of immune aging on vaccine responses","volume":"145","author":"Gustafson","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ebiom.2025.105699_bib20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s43587-022-00292-y","article-title":"Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults","volume":"2","author":"Palacios-Pedrero","year":"2022","journal-title":"Nat Aging"},{"key":"10.1016\/j.ebiom.2025.105699_bib21","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1073\/pnas.1409155111","article-title":"Diversity and clonal selection in the human T-cell repertoire","volume":"111","author":"Qi","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2025.105699_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.arr.2010.06.004","article-title":"Impact of aging on dendritic cell functions in humans","volume":"10","author":"Agrawal","year":"2011","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.ebiom.2025.105699_bib23","doi-asserted-by":"crossref","first-page":"15053","DOI":"10.1073\/pnas.2433717100","article-title":"CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly","volume":"100","author":"Haynes","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2025.105699_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1473-3099(15)00354-0","article-title":"Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b\/3 trial","volume":"16","author":"Hung","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105699_bib25","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.1158\/0008-5472.CAN-14-0473","article-title":"Vaccine-elicited CD8+ T cells cure mesothelioma by overcoming tumor-induced immunosuppressive environment","volume":"74","author":"Tan","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2025.105699_bib26","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0140-6736(21)02717-3","article-title":"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial","volume":"398","author":"Munro","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2025.105699_bib27","article-title":"A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines","volume":"3","author":"Lim","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ebiom.2025.105699_bib28","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.immuni.2021.08.001","article-title":"Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination","volume":"54","author":"Painter","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2025.105699_bib29","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.vaccine.2015.03.036","article-title":"Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials","volume":"33","author":"Jin","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2025.105699_bib30","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1038\/ncomms6317","article-title":"Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients","volume":"5","author":"Kim","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105699_bib31","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/QAD.0000000000003804","article-title":"The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy","volume":"38","author":"Jacobson","year":"2024","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2025.105699_bib32","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41591-024-02894-y","article-title":"Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1\/2 trial","volume":"30","author":"Yarchoan","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2025.105699_bib33","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/infdis\/jiac016","article-title":"SARS-CoV-2 DNA vaccine INO-4800 induces durable immune responses capable of being boosted in a phase 1 open-label trial","volume":"225","author":"Kraynyak","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105699_bib34","first-page":"113","article-title":"Targeting skin dendritic cells to improve intradermal vaccination","volume":"351","author":"Romani","year":"2011","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.ebiom.2025.105699_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137079","article-title":"Robust antibody and cellular responses induced by DNA-only vaccination for HIV","volume":"5","author":"De Rosa","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2025.105699_bib36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.omto.2020.01.009","article-title":"Antimesothelioma immunotherapy by CTLA-4 blockade depends on active PD1-based TWIST1 vaccination","volume":"16","author":"Tan","year":"2020","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.ebiom.2025.105699_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009647","article-title":"Sustained viremia suppression by SHIVSF162P3CN-recalled effector-memory CD8+ T cells after PD1-based vaccination","volume":"17","author":"Wong","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2025.105699_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03350-23","article-title":"A follow-up study: 6-year cART-free virologic control of rhesus macaques after PD-1-based DNA vaccination against pathogenic SHIV SF162P3CN challenge","volume":"11","author":"He","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ebiom.2025.105699_bib39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2025.105699_bib40","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1038\/s41467-023-39096-y","article-title":"Vaccine-induced protection against SARS-CoV-2 requires IFN-\u03b3-driven cellular immune response","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105699_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2025.105699_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn0136","article-title":"Comparative single-cell analysis reveals IFN-\u03b3 as a driver of respiratory sequelae after acute COVID-19","volume":"16","author":"Li","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2025.105699_bib43","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1152\/physiol.00035.2015","article-title":"Sex and gender impact immune responses to vaccines among the elderly","volume":"30","author":"Fink","year":"2015","journal-title":"Physiology"},{"key":"10.1016\/j.ebiom.2025.105699_bib44","article-title":"Impact of SARS-CoV-2 exposure history on the T cell and IgG response","volume":"4","author":"Keeton","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ebiom.2025.105699_bib45","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2025.105699_bib46","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0264-410X(00)00302-9","article-title":"Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine","volume":"19","author":"Roy","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2025.105699_bib47","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(22)00151-9","article-title":"Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India","volume":"399","author":"Khobragade","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2025.105699_bib48","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/S2666-5247(21)00358-X","article-title":"Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults","volume":"3","author":"Ahn","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ebiom.2025.105699_bib49","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","article-title":"A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS","volume":"182","author":"Dai","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2025.105699_bib50","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","article-title":"COVID-19 vaccines and adverse events of special interest: a multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals","volume":"42","author":"Faksova","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2025.105699_bib51","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000053993","article-title":"Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice","volume":"43","author":"Ledwith","year":"2001","journal-title":"Intervirology"},{"key":"10.1016\/j.ebiom.2025.105699_bib52","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2025.105699_bib53","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2025.105699_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019252","article-title":"In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers","volume":"6","author":"Vasan","year":"2011","journal-title":"PLoS One"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:18:20Z","timestamp":1762618700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425001434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":54,"alternative-id":["S2352396425001434"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105699","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An open-label study on the safety and immunogenicity of a PD-1-enhanced DNA vaccine used as a T cell booster for COVID-19","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105699"}}